Allergan begins trials on hair-growth drug
Drugmaker Allergan is recruiting volunteers for clinical trials of a hair-growth treatment based on the active ingredient in Latisse (bimatoprost ophthalmic solution, 0.03 percent), the company’s eyelash-growth treatment. (Source: Modern Medicine)
Link:
Allergan begins trials on hair-growth drug
Latisse gains popularity among those seeking longer, fuller lashes
St. Louis — As women become more familiar and comfortable with the idea of a medication that can help give them the kind of lush, long eyelashes they’ve always wanted, physicians have increasingly found themselves prescribing Latisse (bimatoprost ophthalmic solution 0.03 percent, Allergan) and addressing eyelash issues previously dealt with primarily at the cosmetics counter. (Source: Modern Medicine)
See the original post:
Latisse gains popularity among those seeking longer, fuller lashes
(sponsored multimedia) Latisse™ (bimatoprost ophthalmic solution) 0.03%: A National Summit on New Aesthetic Opportunities
(Source: Modern Medicine)
Read this article:
(sponsored multimedia) Latisse™ (bimatoprost ophthalmic solution) 0.03%: A National Summit on
New Aesthetic Opportunities
Epione Beverly Hills- Treatment For Sun Damaged Skin
- Breast Plastic Surgery – Symmetry, Form and Beauty
- Facial Acne Scars: Erasing The Marks Of Your Youth
- Danielle Staub from the Real Housewives of New Jersey receives Botox treatment at Epione Beverly Hills
- Do You Hate Your Acne Scars?
- The return of perfect skin
- Would You Like To Get Fuller Lips?
- Facial Wrinkle Removal: Getting Rid Of Facial Wrinkles
- Acne Scars: Information About Reducing The Appearance Of Acne Scars
- Cellulite Removal: Know The Facts